SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [85C10] | 11-019

SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [85C10] | 11-019 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Virus

Homology: Highly-specific to SARS-CoV-2 nucleoprotein; does not cross-react with nucleoprotein from SARS-CoV or other coronaviruses

Immunogen: SARS-CoV-2 nucleoprotein (NP) specific peptide

Research Area: Infectious Disease, COVID-19

Tested Application: E, WB

Application: ELISA

Specificiy: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: SARS-CoV-2 (COVID-19) Nucleoprotein Antibody [85C10] is affinity chromatography purified via peptide column.

Clonality: Recombinant Monoclonal

Clone: 85C10

Isotype: IgG1k

Conjugate: Unconjugated

Physical State: Liquid

Buffer: 1X PBS, 0.02% NaN3

Concentration: N/A

Storage Condition: SARS-CoV-2 (COVID-19) Nucleoprotein Antibody [85C10] can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Alternate Name: SARS-CoV-2 (COVID-19) Nucleoprotein Antibody [85C10]: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: We have leveraged our next-generation rabbit mAb discovery platform to develop recombinant rabbit monoclonal antibodies with extremely high sensitivity and specificity to SARS-CoV-2. These antibodies, which include clones 75G5a, 84C4a, 84D7, 85C1, 85C10, 85B4, and 85E9 can be paired in sandwich detection assay and used to detect nucleoprotein (NP) antigen from SARS-CoV-2. Antibodies 75G5a, 84C4a, 84D7, 85C10, and 85B4 do not cross-react to the highly related SARS-CoV virus or to any other coronaviruses tested. Sandwich ELISA detection using TMB/acid developer reliably detects NP antigen in the pg/mL range, and sensitivity is expected to be even higher when using more sensitive developer strategies. This panel of antibodies can be used as raw materials for diagnostic kits and can be applied to lateral flow systems for diagnostic detection of COVID-19.